Skip to main content

Advertisement

SpringerLink
Log in

An evidence-based perspective on warfarin and the growing skeleton

  • Letter
  • Published:
Osteoporosis International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Avila ML, Pullenayegum E, Williams S, Shammas A, Stimec J, Sochett E, Marr K, Brandao LR (2015) Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study. Osteoporos Int. doi:10.1007/s00198-015-3411-8

    PubMed  Google Scholar 

  2. Bendaly EA, DiMeglio LA, Fadel WF, Hurwitz RA (2015) Bone density in children with single ventricle physiology. Pediatr Cardiol 36:779–785

    Article  PubMed  Google Scholar 

  3. Jones AR, Zacharin MR, Cameron FJ, Simm PJ (2015) Bone density assessment in a tertiary paediatric centre over 13 years: referral patterns and limitations. J Paediatr Child Health 51:608–613

    Article  PubMed  Google Scholar 

  4. Tufano A, Coppola A, Contaldi P, Franchini M, Minno GD (2015) Oral anticoagulant drugs and the risk of osteoporosis: new anticoagulants better than old? Semin Thromb Hemost 41:382–388

    Article  CAS  PubMed  Google Scholar 

  5. Misra D, Zhang Y, Peloquin C, Choi HK, Kiel DP, Neogi T (2014) Incident long-term warfarin use and risk of osteoporotic fractures: propensity-score matched cohort of elders with new onset atrial fibrillation. Osteoporos Int 25:1677–1684

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Sugiyama T, Kugimiya F, Kono S, Kim YT, Oda H (2015) Warfarin use and fracture risk: an evidence-based mechanistic insight. Osteoporos Int 26:1231–1232

    Article  CAS  PubMed  Google Scholar 

  7. Byreddy DV, Bouchonville MF II, Lewiecki EM (2015) Drug-induced osteoporosis: from fuller Albright to aromatase inhibitors. Climacteric 18(Suppl 2):39–46

    Article  PubMed  Google Scholar 

  8. Veronese N, Bano G, Bertozzo G, Granziera S, Solmi M, Manzato E, Sergi G, Cohen AT, Correll CU (2015) Vitamin K antagonists’ use and fracture risk: results from a systematic review and meta-analysis. J Thromb Haemost 13:1665–1675

    Article  CAS  PubMed  Google Scholar 

  9. Zhao SS, Lin ZY, Zhu Y (2016) Vitamin K antagonists’ use and fracture risk: results from a systematic review and meta-analysis: comment. J Thromb Haemost 14:219–221

    Article  CAS  PubMed  Google Scholar 

  10. Veronese N, Bano G, Granziera S, Solmi M, Cohen AT, Correll CU (2016) Vitamin K antagonists’ use and fracture risk: results from a systematic review and meta-analysis: reply. J Thromb Haemost 14:221–223

    Article  CAS  PubMed  Google Scholar 

  11. Lai HC, Chien WC, Chung CH, Lee WL, Wu TJ, Wang KY, Liu CN, Liu TJ (2015) Atrial fibrillation, CHA2DS2-VASc score, antithrombotics and risk of non-traffic-, non-cancer-related bone fractures: a population-based cohort study. Eur J Intern Med 26:798–806

    Article  PubMed  Google Scholar 

  12. Sugiyama T, Kim YT, Oda H (2015) Warfarin use might increase hip fracture risk in older diabetic adults treated with sulfonylureas. http://www.bmj.com/content/351/bmj.h6223/rr. Accessed 11 December 2015

  13. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A (2015) Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis. BMJ 351:h6223

    Article  PubMed  PubMed Central  Google Scholar 

  14. Romley JA, Gong C, Jena AB, Goldman DP, Williams B, Peters A (2016) Re: Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis. http://www.bmj.com/content/351/bmj.h6223/rr-1. Accessed 29 January 2016

  15. Azuma K, Shiba S, Hasegawa T, Ikeda K, Urano T, Horie-Inoue K, Ouchi Y, Amizuka N, Inoue S (2015) Osteoblast-specific γ-glutamyl carboxylase-deficient mice display enhanced bone formation with aberrant mineralization. J Bone Miner Res 30:1245–1254

    Article  CAS  PubMed  Google Scholar 

  16. Sugiyama T, Kim YT, Oda H (2016) Skeletal adaptation to mechanical strain: a key role in osteoporosis. In: Shimada Y, Miyakoshi N (eds) Osteoporosis in orthopedics: assessment and therapeutic options. Springer, Tokyo, pp 3–22

    Chapter  Google Scholar 

  17. Vaninetti N, Kirkland S, Thompson K, Theriault C, Prior JC, Kovacs C, Adachi JD, Towheed TE, Leslie WD, Davison KS, Morin SN, Goltzman D, Kaiser SM (2015) Warfarin use was not associated with changes in bone mineral density in the population-based Canadian Multicentre Osteoporosis Study (CaMos). Can J Diabetes 39:544

    Article  Google Scholar 

  18. Watzka M, Geisen C, Scheer M, Wieland R, Wiegering V, Dorner T, Laws HJ, Gumruk F, Hanalioglu S, Unal S, Albayrak D, Oldenburg J (2014) Bleeding and non-bleeding phenotypes in patients with GGCX gene mutations. Thromb Res 134:856–865

    Article  CAS  PubMed  Google Scholar 

  19. Huang ZB, Wan SL, Lu YJ, Ning L, Liu C, Fan SW (2015) Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials. Osteoporos Int 26:1175–1186

    Article  CAS  PubMed  Google Scholar 

  20. Saito M, Marumo K (2016) Collagen cross-links as a determinant of bone quality. In: Shimada Y, Miyakoshi N (eds) Osteoporosis in orthopedics: assessment and therapeutic options. Springer, Tokyo, pp 35–54

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Orthopaedic Surgery, Saitama Medical University, 38 Morohongo, Moroyama, Saitama, 350-0495, Japan

    T. Sugiyama, Y. Kono, K. Sekiguchi, Y. T. Kim & H. Oda

Authors
  1. T. Sugiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Kono
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Sekiguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. T. Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Oda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T. Sugiyama.

Ethics declarations

Conflict of Interest

None.

Additional information

A response to these comments can be found at doi: 10.1007/s00198-016-3587-6

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugiyama, T., Kono, Y., Sekiguchi, K. et al. An evidence-based perspective on warfarin and the growing skeleton. Osteoporos Int 27, 2883–2884 (2016). https://doi.org/10.1007/s00198-016-3588-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00198-016-3588-5

Keywords

Search

Navigation